Indeed, elevated levels of IL-34 have been associated with poor prognosis in primary lung cancer and such levels significantly correlate with the development of chemoresistance and progression in non-viral hepatocellular carcinoma and in basal breast cancer [40, 43, 46]. Here, IL34 is linked to lung carcinoma.